- Home
- CIG vs KYMR Comparison
CIG vs KYMR Comparison
Compare CIG & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIG | KYMR |
|---|---|---|
| Founded | 1952 | 2015 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CIG | KYMR |
|---|---|---|
| Price | $2.03 | $83.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 23 |
| Target Price | N/A | ★ $105.35 |
| AVG Volume (30 Days) | ★ 3.2M | 1.5M |
| Earning Date | 03-19-2026 | 11-04-2025 |
| Dividend Yield | ★ 10.96% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $7,960,960,695.00 | $43,735,000.00 |
| Revenue This Year | N/A | $18.71 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.30 | ★ N/A |
| Revenue Growth | ★ 9.92 | N/A |
| 52 Week Low | $1.59 | $19.45 |
| 52 Week High | $2.30 | $103.00 |
Technical Indicators
Market Signals| Indicator | CIG | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 59.56 |
| Support Level | $1.96 | $82.55 |
| Resistance Level | $2.04 | $85.41 |
| Average True Range (ATR) | 0.04 | 5.12 |
| MACD | -0.00 | -0.52 |
| Stochastic Oscillator | 43.59 | 47.93 |
Price Performance
Historical ComparisonAbout CIG Comp En De Mn Cemig ADS
Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.